Entry |
|
Symbol |
PPP3CC
|
Name |
(RefSeq) serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
|
KO |
K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
Organism |
hmh Hylobates moloch (silvery gibbon)
|
Pathway |
hmh04625 | C-type lectin receptor signaling pathway |
hmh04650 | Natural killer cell mediated cytotoxicity |
hmh04658 | Th1 and Th2 cell differentiation |
hmh04660 | T cell receptor signaling pathway |
hmh04662 | B cell receptor signaling pathway |
hmh05022 | Pathways of neurodegeneration - multiple diseases |
hmh05163 | Human cytomegalovirus infection |
hmh05166 | Human T-cell leukemia virus 1 infection |
hmh05167 | Kaposi sarcoma-associated herpesvirus infection |
hmh05170 | Human immunodeficiency virus 1 infection |
hmh05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:hmh00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
116461844 (PPP3CC)
04310 Wnt signaling pathway
116461844 (PPP3CC)
04370 VEGF signaling pathway
116461844 (PPP3CC)
04020 Calcium signaling pathway
116461844 (PPP3CC)
04022 cGMP-PKG signaling pathway
116461844 (PPP3CC)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
116461844 (PPP3CC)
04218 Cellular senescence
116461844 (PPP3CC)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
116461844 (PPP3CC)
04650 Natural killer cell mediated cytotoxicity
116461844 (PPP3CC)
04660 T cell receptor signaling pathway
116461844 (PPP3CC)
04658 Th1 and Th2 cell differentiation
116461844 (PPP3CC)
04659 Th17 cell differentiation
116461844 (PPP3CC)
04662 B cell receptor signaling pathway
116461844 (PPP3CC)
09152 Endocrine system
04922 Glucagon signaling pathway
116461844 (PPP3CC)
04921 Oxytocin signaling pathway
116461844 (PPP3CC)
04924 Renin secretion
116461844 (PPP3CC)
09156 Nervous system
04724 Glutamatergic synapse
116461844 (PPP3CC)
04728 Dopaminergic synapse
116461844 (PPP3CC)
04720 Long-term potentiation
116461844 (PPP3CC)
09158 Development and regeneration
04360 Axon guidance
116461844 (PPP3CC)
04380 Osteoclast differentiation
116461844 (PPP3CC)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
116461844 (PPP3CC)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
116461844 (PPP3CC)
05170 Human immunodeficiency virus 1 infection
116461844 (PPP3CC)
05163 Human cytomegalovirus infection
116461844 (PPP3CC)
05167 Kaposi sarcoma-associated herpesvirus infection
116461844 (PPP3CC)
09171 Infectious disease: bacterial
05152 Tuberculosis
116461844 (PPP3CC)
09164 Neurodegenerative disease
05010 Alzheimer disease
116461844 (PPP3CC)
05014 Amyotrophic lateral sclerosis
116461844 (PPP3CC)
05020 Prion disease
116461844 (PPP3CC)
05022 Pathways of neurodegeneration - multiple diseases
116461844 (PPP3CC)
09165 Substance dependence
05031 Amphetamine addiction
116461844 (PPP3CC)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
116461844 (PPP3CC)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:hmh01009]
116461844 (PPP3CC)
Enzymes [BR:hmh01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
116461844 (PPP3CC)
Protein phosphatases and associated proteins [BR:hmh01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
116461844 (PPP3CC)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
511 aa
MSGRRFHLSTTDRVIKAVPFPPTQRLTFKEVFENGKPKVDVLKNHLVKEGRLEEEVALKI
INDGAAILRQEKTMIEVDAPITVCGDIHGQFFDLMKLFEVGGSPSNTRYLFLGDYVDRGY
FSIECVLYLWSLKINHPKTLFLLRGNHECRHLTDYFTFKQECRIKYSEQVYDACMETFDC
LPLAALLNQQFLCVHGGMSPEITSLDDIRKLDRFTEPPAFGPVCDLLWSDPSEDYGNEKT
LEHYTHNTVRGCSYFYSYPAVCEFLQNNNLLSIIRAHEAQDAGYRMYRKSQATGFPSLIT
IFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEM
LVNVLNICSDDELISDDEAEGSTTVRKEIIRNKIRAIGKMARVFSILRQESESVLTLKGL
TPTGTLPLGVLSGGKQTIETATVEAVEAREAIRGFSLQHKIRSFEEARGLDRINERMPPR
KDSIQADGPMKSITSAHSHAAHRSNQGKKAQ |
NT seq |
1536 nt +upstreamnt +downstreamnt
atgtccgggaggcgcttccacctctccaccaccgaccgcgtcatcaaagctgtccccttt
cctccaacccaacggcttacttttaaagaagtatttgagaatgggaaacctaaagttgat
gttttaaaaaaccatttggtaaaggaaggacgactggaagaggaagtagccttaaagata
atcaatgatggggctgccatcctgaggcaagagaagactatgatagaagtagatgctcca
atcacagtatgtggtgatattcatggacaattctttgacctaatgaagttatttgaagtt
ggaggatcacctagtaacacacgctacctctttctgggtgactatgtggacagaggctat
ttcagtatagagtgtgtgctgtatttatggagtttaaagattaatcatcccaaaacattg
tttctgcttcggggaaatcatgaatgcaggcatcttacagactatttcaccttcaaacag
gaatgtcgaatcaaatattcggaacaggtatatgatgcctgtatggagacatttgactgt
cttcctcttgctgccctcttaaaccagcagtttctctgtgtacatggaggaatgtcacct
gaaattacttctttagatgacattaggaaattagacaggtttacggaacctcccgccttt
ggacctgtgtgtgacctgctttggtctgatccctcagaggattatggcaatgagaagacc
ttggagcactatacccacaacactgtccgagggtgctcttatttctacagttaccctgca
gtttgtgaatttttgcagaacaataatttactatcaattatcagagcccatgaagcccaa
gatgctgggtatcgaatgtacaggaagagtcaagcaacaggctttccatcacttattaca
attttctctgcccccaattacctagatgtctataacaataaagctgctgtgttgaaatac
gaaaataatgtcatgaatatcaggcagtttaactgttctccacacccctactggcttcca
aactttatggatgttttcacatggtctttgccttttgttggggaaaaagtcacagagatg
ctggtaaatgtgctcaacatatgctctgatgatgaactgatttctgatgatgaagcagaa
ggaagcactacagttcgtaaggagatcatcaggaataagatcagagccattgggaagatg
gcacgggtcttttcaattcttcggcaagaaagtgagagtgtgctgactctcaagggcctg
actcccacaggcacgctccctctgggcgtcctctcaggaggcaagcagactatcgagaca
gccacagtagaagcggtagaggcccgggaagccatcagagggttctcgcttcagcacaag
atccggagttttgaagaagcgcgaggtctggaccgaattaatgagcgaatgccaccccga
aaggatagcatacaggctgatgggccaatgaaatccataacctcagcacactcacatgct
gcacacaggagcaaccaagggaagaaagcccagtaa |